Skip to Main Content

Paper Details

Results of the U.S. Food and Drug Administration continued access clinical trial of the GORE HELEX septal occluder for secundum atrial septal defect.
JACC Cardiovasc Interv
15
2014
Author NameAffiliation
Jonathan J RomeChildren's Hospital of Philadelphia
Evan M ZahnHeart Institute and Department of Pediatrics at Cedars-Sinai Medical Center
Larry A LatsonJoe DiMaggio Children's Hospital
  • 1 - 3

Datasets

Release 1.2